Because BP-Btz is designed to only deliver “free” Btz locally after the BP moiety binds to the bone and the Btz is released as a consequence of the local acidic environment, we anticipated that BP-Btz would cause less severe pancytopenia or thrombocytopenia than Btz. Here, CASC3 is linked to Thrombocytopenia.